Medicines have a major impact on health and wellbeing. However, it is also important to recognize the problems of inappropriate drug use which have demonstrated the need for drug utilization research, a cross-disciplinary and multi-professional science with the aim to describe and understand the use of medicines in the society. The introductory presentation on Future Trends in Drug Utilization Research aims to give an overview of current trends and what kind of drug utilization studies that will be needed in the future to address the growing pressures on all healthcare systems with aging populations, rising patient expectations, stricter clinical targets, and expensive new medicines.

The use of computerized databases has greatly facilitated studies of drug utilization. Over the years more and more data have become available in registries, claims databases and medical records. Today, we face a rapid growth of data coming from other sources, and the term “big data” has been used to refer to data sets that are too large or complex for traditional data-processing application software to adequately deal with. Considerable amounts of healthcare data are generated every day, some of them from data sources to large extent unexplored or unused in drug utilization research such as clinical records systems, mail traffic, social media and various devices. Even though new computer techniques and machine learning have been developed, there are still many challenges such as how to deal with missing data, unstructured data, poor data validity and interoperability. The new opportunities and challenges will be explored in the session Drug Utilization Research in the Era of Big Data.

Drug utilization studies are valuable tools in health policy. The session on Real World Evidence in health care decision-making focuses on how observational studies can contribute to shape pharmaceutical policy and address issues such as unmet need, access to medicines, pricing, cost containment and irrational use of medicines. Many strategies aimed at improving prescribing behavior have been proposed and adopted, and examples of drug utilization studies along the life-cycle of medicines will be shown. The topic is growing in importance given ever increasing pressure on resources through changes in demographics, the continued launch of new premium priced drugs to address areas of unmet need, and financial concerns.

Precision medicine is an approach for disease treatment and prevention taking individual variability in genes, environment, and lifestyle into account for each person. Such an approach allows a more accurate prediction on which treatment and prevention strategies that will work for different groups of people, compared to the traditional approaches where disease treatment and prevention are developed for the average person, with less consideration for the differences between individuals. The session use of big data in the development of precision medicine aim to give an overview on what precision medicine is, current strategies in the field, how different types of data may be used in and what implications the development of precision medicine has on future drug utilization research. 

Who should attend?

The International Conference on Pharmaceutical Research and Practice (ICPRP) is an interdisciplinary forum and will serve as an open forum for discussion. This conference will invite researchers, academicians and practitioners in disseminating, reporting and sharing their experiences, innovations, ideas, and research results. Thus, this conference will discuss the topics:

  1. Pharmacology/Physiology
  2. Clinical Pharmacy
  3. Pharmacy Practice
  4. Pharmacy Education
  5.  Pharmaceutical Technology
  6. Pharmaceutical Chemistry